Related Experiment Video
Updated: Oct 12, 2025
Sound Source Localization Testing in Single-sided Deafness Following Bone Conduction Intervention
Published on: December 20, 2024
Multicenter Results With an Active Transcutaneous Bone Conduction Implant in Patients With Single-sided Deafness
Alexander M Huber1,2, Bernd Strauchmann1,2, Marco D Caversaccio3,4
1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Zürich.
Objective:
To evaluate the audiological and subjective benefit from hearing rehabilitation with an active bone conduction implant in subjects with single-sided sensorineural deafness (SSD).
Study Design:
Prospective, multicenter, single-subject repeated measures.
Setting:
Tertiary referral center, five clinics in Germany and Switzerland.
Patients:
Seventeen subjects aged 18 years and older with severe to profound unilateral sensorineural hearing loss and contralateral normal hearing were followed up for 24 months.
Intervention:
Active bone conduction implant.
Main Outcome Measures:
Speech understanding in noise was assessed in three situations: with signal from front, deaf, or normal hearing side (with noise from front in all set-ups). Subjective benefit was evaluated using the Speech, Spatial, and Qualities of Hearing (SSQ-B) and Bern Benefit in Single-Sided Deafness (BBSS) questionnaire.
Results:
When the signal was coming from the deaf side the mean improvement of the speech reception threshold in noise ranged from 1.5 up to 2.2 dB with the device and was statistically and clinically significant at all tested timepoints. No significant difference between the aided and unaided situation was found when signal and noise were coming from the front. With the signal from the normal hearing side no clinically significant difference, that is, greater than 1 dB between the aided and unaided situation was found. The SSQ-B and BBSS questionnaire showed an overall improvement with no significant difference between time points.
Conclusions:
The study demonstrates long-term efficacy and benefit of the device in adults with SSD. Patients reported substantial and persistent subjective benefit from the active bone conduction implant.
